Haxone-T 562.5 Injection
By Haxone-T
Rx
1 Injection in a Vial

Composition
Ceftriaxone(500mg) + Tazobactum(62.5mg)

Manufacturer - Hiya Lifesciences Pvt Ltd
SCO 42, 1st Floor, Swastic Vihar, Mansa Devi Complex, Sector 5, Panchkula, Haryana 134109, India

Expires on or after
September, 2025

liver
Haxone-T 562.5 Injection requires caution when used by individuals with severe liver disease. It may be necessary to adjust the dosage of Haxone-T 562.5 Injection in these patients. It is important to consult your doctor before using this medication if you have severe liver disease. However, for patients with mild to moderate liver disease, dose adjustment of Haxone-T 562.5 Injection is typically not necessary.

kidney
Caution is advised regarding the use of Haxone-T 562.5 Injection in patients with kidney disease. It is important to consult your doctor for guidance on its use in such cases.

alcohol
When using Haxone-T 562.5 Injection, it is safe to drink alcohol as there are no harmful side effects. For advice on alcohol consumption during pregnancy, consult your doctor.

driving
When using Haxone-T 562.5 Injection, you may experience decreased alertness, vision changes, drowsiness, and dizziness. Avoid driving if these effects are present.

pregnancy
Haxone-T 562.5 Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Haxone-T 562.5 Injection must be used cautiously during breastfeeding. It is advisable to pause breastfeeding until the mother's treatment is finished and the drug has cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹98
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 18-Nov-2024